Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Geophagy protects stomach against toxins, parasites and pathogens

Geophagy protects stomach against toxins, parasites and pathogens

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

Shield raises EUR8.2M through Series A financing

Shield raises EUR8.2M through Series A financing

HbA1c glucose monitoring test not effective for diagnosing diabetes patients with kidney failure

HbA1c glucose monitoring test not effective for diagnosing diabetes patients with kidney failure

YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

AHRQ: 94% of women hospitalized for pregnancy and delivery in the U.S. had complications

iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine

iBioLaunch Platform successfully expresses hookworm-derived molecule for potential vaccine

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

NEJM publishes ZYTIGA plus prednisone Phase 3 trial data in metastatic castration-resistant prostate cancer

Analysis of Nubian-era mummies finds schistosomiasis spread from altering environment

Analysis of Nubian-era mummies finds schistosomiasis spread from altering environment

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex Incivek receives FDA approval for treatment of chronic hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

Pieris' PRS-080 preclinical data in anemia presented at International BioIron Society Meeting

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

African Americans with SLE have higher antibody response to influenza vaccination: Study

African Americans with SLE have higher antibody response to influenza vaccination: Study

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

Medivir reports positive results from ASPIRE TMC435 phase 2b study for genotype 1 chronic hepatitis C

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.